SARAH Study Completes Enrolment

Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016


http://www.virtualpressoffice.com/p...eToDisableHistory=Y&menuName=News&sId=&sInfo=

mce-anchorPARIS, March 4, 2015 /PRNewswire/ -- SARAH, a large French study of patients with advanced, inoperable primary liver cancer (hepatocellular carcinoma, or HCC) has completed patient enrolment, exceeding its 400-patient target, according to its principal investigator, Professor Valerie Vilgrain MD, PhD, Department of Radiology, Beaujon Hospital, Assistance Publique - Hopitaux de Paris (AP-HP) and Universite Paris Diderot, Sorbonne Paris Cite, France.